Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Thursday, April 27, 2017

Neuroplasticity, Neuroregeneration, and Brain Repair

Your doctor should be able to get some takeaways from this conference to update your stroke recovery protocol to 100% recovery. If 100% recovery is not your doctors goal for you then you have a fucking incompetent asshole for a doctor.
http://www.nyas.org/Events/Detail.aspx?cid=f42ad038-6416-4c56-a12a-9782725d3f57
June 13 - 14, 2017
The New York Academy of Sciences
Presented by Eli Lilly and Company and the New York Academy of Sciences
Register Now
  • Early Bird Deadline:
    May 01, 2017
  • Poster Abstract Deadline:
    April 17, 2017
  • Fellowship Deadline:
    April 17, 2017
  • Add to Outlook/Google/iCal
 
Strategies to stimulate neuroregeneration and neurorestoration hold promise to vastly improve the treatment of a range of neurological diseases and injuries, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), spinal cord injury, and multiple sclerosis (MS). While progress has been made in understanding the cellular mechanisms of these processes, more research is needed in order to translate this knowledge into more effective treatments that restore function to the central nervous system.
This 2-day convening will bring together leading researchers, clinicians, industry, and governmental stakeholders from around the world to explore neuroregenerative processes and identify strategies for translating knowledge into treatments for neurodegenerative diseases and nervous system injuries. Plenary sessions will be designed to present emerging basic and clinical research in the following areas: neurodegenerative disease-modifying therapies that slow progression; mechanisms of neuroplasticity, including the role of dendritic spines, axonal growth, synaptic plasticity, inflammation, oxidative stress, mitochondrial function, and autophagy; glial function in the central nervous system; cutting-edge strategies to promote and modify neurogenesis; and biomarker and imaging modalities for neuroregeneration. The conference will conclude with an interactive panel discussion exploring future directions, critical open questions, and promising therapies in the field of neuroregeneration and neurorestoration.

No comments:

Post a Comment